Skip to Main Content


Report on the FDA Cannabis Hearing: Passionate Presenters Urge Clarity in Regulation of Complex Industry

July 2019 - Westlaw Expert Analysis
Social Logo Social Logo Social Logo

On Friday, May 31, 2019, the FDA convened a public hearing to take comments from more than 100 presenters addressing a wide range of scientific, marketing, safety, and efficacy issues pertaining to products containing cannabis or cannabis-derived compounds. This day-long session was held at the U.S. Food and Drug Administration White Oak Campus in Silver Spring, Maryland.

Read the report here.

Related Attorneys

Related Article

INSIGHT: Shareholder's Intention to Start Proxy Fight Not Enough to Inspect Corporate Books More
A podcast that analyzes legal issues surrounding autonomous vehicles.
Perspectives on employee benefits, executive compensation and ERISA litigation to help you attract and retain talent.
lingua negoti
The language of business.
Ohio Environmental
Insights and commentary for the business and legal community.